Ontology type: schema:ScholarlyArticle
2015-10
AUTHORSJun Ho Jang, Hironori Harada, Hirohiko Shibayama, Ryutaro Shimazaki, Hyeoung-Joon Kim, Kenichi Sawada, Kinuko Mitani
ABSTRACTDarbepoetin alfa (DA) is a standard treatment for anemia in lower-risk MDS. However, to date there has been no comparative study to investigate the initial dosage. We, thus, conducted a randomized controlled trial to elucidate the optimal initial dosage of DA. International Prognostic Scoring System low or intermediate-1 risk MDS patients with hemoglobin levels ≤9.0 g/dL, serum erythropoietin levels ≤500 mIU/mL, and red blood cell transfusion dependency were enrolled. Patients were randomized to receive DA either at 60, 120, or 240 μg/week for 16 weeks followed by continuous administration with dose adjustment up to 48 weeks. Of 17, 18, and 15 patients in the 60, 120, and 240 μg DA groups included in the efficacy analysis, 64.7, 44.4, and 66.7 %, respectively, achieved the primary endpoint (major or minor erythroid response), while 17.6, 16.7, and 33.3 % achieved major erythroid responses in the initial 16-week period. No clinically significant safety concerns were identified. DA reduced the transfusion requirements effectively and safely in transfusion-dependent, lower-risk MDS patients. Given the highest achievement rate of the major erythroid response in the 240 μg group and the absence of dose-dependent adverse events, 240 μg weekly is the optimal initial dosage. More... »
PAGES401-412
http://scigraph.springernature.com/pub.10.1007/s12185-015-1862-5
DOIhttp://dx.doi.org/10.1007/s12185-015-1862-5
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1025191030
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26323997
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged, 80 and over",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Darbepoetin alfa",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Dose-Response Relationship, Drug",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Erythrocyte Transfusion",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Myelodysplastic Syndromes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Risk Factors",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"name": [
"Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"
],
"type": "Organization"
},
"familyName": "Jang",
"givenName": "Jun Ho",
"id": "sg:person.0635513500.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635513500.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Juntendo University",
"id": "https://www.grid.ac/institutes/grid.258269.2",
"name": [
"Department of Hematology and Oncology, Hiroshima University Hospital, Hiroshima, Japan",
"Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Harada",
"givenName": "Hironori",
"id": "sg:person.01126502475.24",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126502475.24"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Osaka University",
"id": "https://www.grid.ac/institutes/grid.136593.b",
"name": [
"Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan"
],
"type": "Organization"
},
"familyName": "Shibayama",
"givenName": "Hirohiko",
"id": "sg:person.01273323113.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273323113.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Kyowa Hakko Kirin (Japan)",
"id": "https://www.grid.ac/institutes/grid.473316.4",
"name": [
"R&D Division, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan"
],
"type": "Organization"
},
"familyName": "Shimazaki",
"givenName": "Ryutaro",
"id": "sg:person.01305704201.18",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01305704201.18"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Chonnam National University Hwasun Hospital",
"id": "https://www.grid.ac/institutes/grid.411602.0",
"name": [
"Department of Hematology/Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Korea"
],
"type": "Organization"
},
"familyName": "Kim",
"givenName": "Hyeoung-Joon",
"id": "sg:person.0617770714.19",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617770714.19"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Akita University",
"id": "https://www.grid.ac/institutes/grid.251924.9",
"name": [
"Akita University, Akita, Japan"
],
"type": "Organization"
},
"familyName": "Sawada",
"givenName": "Kenichi",
"id": "sg:person.0614414637.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614414637.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Dokkyo Medical University",
"id": "https://www.grid.ac/institutes/grid.255137.7",
"name": [
"Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, 880, Kitakobayashi, Mibu-machi, Shimotsuga-gun, 321-0293, Tochigi, Japan"
],
"type": "Organization"
},
"familyName": "Mitani",
"givenName": "Kinuko",
"id": "sg:person.01117236337.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117236337.14"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1111/j.1365-2141.2007.06546.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004811324"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1998.01085.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1008861337"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.3109/10428191003728610",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009375524"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdi400",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012099912"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1093/annonc/mdi400",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012099912"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.2003.04153.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1012572767"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2008.07181.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1013944855"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2009-03-211797",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019476660"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2009-03-211797",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019476660"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0140-6736(03)14567-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019906916"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2004.05288.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1019926181"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.14.2885",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1020174977"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.1995.tb08909.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1024467708"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1634/theoncologist.12-10-1264",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026462072"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-008-0450-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026717109",
"https://doi.org/10.1007/s00277-008-0450-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s00277-008-0450-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026717109",
"https://doi.org/10.1007/s00277-008-0450-7"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1185/03007995.2011.561834",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1030966745"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2007-06-096370",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031702469"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/j.leukres.2010.05.030",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036408204"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2003-07-2252",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040095574"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1046/j.1365-2141.1997.4013211.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1040833966"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2012-03-420489",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042747172"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/cncr.22343",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043835071"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2007.15.4906",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044023105"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.06.150",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044791769"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2005.06.150",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044791769"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1002/ajh.21316",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1045670181"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1111/j.1365-2141.2006.06070.x",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1046566146"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1182/blood-2013-07-512442",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048488834"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/0145-2126(91)90025-o",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052668900"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1517/14712591003709713",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1067588099"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074587668",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077160478",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077232356",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077332500",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1083056512",
"type": "CreativeWork"
}
],
"datePublished": "2015-10",
"datePublishedReg": "2015-10-01",
"description": "Darbepoetin alfa (DA) is a standard treatment for anemia in lower-risk MDS. However, to date there has been no comparative study to investigate the initial dosage. We, thus, conducted a randomized controlled trial to elucidate the optimal initial dosage of DA. International Prognostic Scoring System low or intermediate-1 risk MDS patients with hemoglobin levels \u22649.0 g/dL, serum erythropoietin levels \u2264500 mIU/mL, and red blood cell transfusion dependency were enrolled. Patients were randomized to receive DA either at 60, 120, or 240 \u03bcg/week for 16 weeks followed by continuous administration with dose adjustment up to 48 weeks. Of 17, 18, and 15 patients in the 60, 120, and 240 \u03bcg DA groups included in the efficacy analysis, 64.7, 44.4, and 66.7 %, respectively, achieved the primary endpoint (major or minor erythroid response), while 17.6, 16.7, and 33.3 % achieved major erythroid responses in the initial 16-week period. No clinically significant safety concerns were identified. DA reduced the transfusion requirements effectively and safely in transfusion-dependent, lower-risk MDS patients. Given the highest achievement rate of the major erythroid response in the 240 \u03bcg group and the absence of dose-dependent adverse events, 240 \u03bcg weekly is the optimal initial dosage.",
"genre": "research_article",
"id": "sg:pub.10.1007/s12185-015-1862-5",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isFundedItemOf": [
{
"id": "sg:grant.5847960",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.6121672",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.6123606",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.5874923",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1076985",
"issn": [
"0925-5710",
"1865-3774"
],
"name": "International Journal of Hematology",
"type": "Periodical"
},
{
"issueNumber": "4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "102"
}
],
"name": "A randomized controlled trial comparing darbepoetin alfa doses in red blood cell transfusion-dependent patients with low- or intermediate-1 risk myelodysplastic syndromes",
"pagination": "401-412",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"7802765ea9bbffe5d6b51774d94aceb8f791e43e5edc9019dc6895f0d64cfa80"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26323997"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"9111627"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12185-015-1862-5"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1025191030"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12185-015-1862-5",
"https://app.dimensions.ai/details/publication/pub.1025191030"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-10T14:12",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8660_00000522.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1007%2Fs12185-015-1862-5"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-015-1862-5'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-015-1862-5'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-015-1862-5'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-015-1862-5'
This table displays all metadata directly associated to this object as RDF triples.
265 TRIPLES
21 PREDICATES
70 URIs
30 LITERALS
18 BLANK NODES